If you liked this article you might like

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta